FMP

FMP

Enter

RCEL - AVITA Medical, Inc.

Financial Summary of AVITA Medical, Inc.(RCEL), AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States,

photo-url-https://financialmodelingprep.com/image-stock/RCEL.png

AVITA Medical, Inc.

RCEL

NASDAQ

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

10.03 USD

0.57 (5.68%)

About

ceo

Mr. James M. Corbett

sector

Healthcare

industry

Medical - Devices

website

https://www.avitamedical.com

exchange

NASDAQ

Description

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in pat...

CIK

0001762303

ISIN

US05380C1027

CUSIP

05380C102

Address

28159 Avenue Stanford

Phone

661 367 9170

Country

US

Employee

207

IPO Date

May 14, 2012

Summary

CIK

0001762303

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

05380C102

ISIN

US05380C1027

Country

US

Price

10.03

Beta

1.29

Volume Avg.

213.39k

Market Cap

257.84M

Shares

-

52-Week

9.16-21.7

DCF

12.06

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-7.16

P/B

-

Website

https://www.avitamedical.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest RCEL News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep